VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production. (Q45212003)
Jump to navigation
Jump to search
scientific article published in January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production. |
scientific article published in January 2005 |
Statements
VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production (English)
Mizuho Kojima
Tetsuhide Ito
Takamasa Oono
Terumasa Hisano
Hisato Igarashi
Yoshiyuki Arita
Robert T Jensen